Overview

Tolerability of Grazax in Patients With Hayfever in Real Life Settings

Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety profile of specific immunotherapy with Grazax for three consecutive grass pollen seasons.
Phase:
Phase 4
Details
Lead Sponsor:
ALK-Abelló A/S